Standard Chemotherapy With of Without Axitinib in Malignant Mesothelioma

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2009
The purpose of this study is to investigate the effects of axitinib, a potent angiogenesis inhibitor, on tissue and clinical outcome in combination with chemotherapy given to patients with mesothelioma
Epistemonikos ID: cf3b6c2e2a9095820d82c3fd39fbac4df189de86
First added on: May 05, 2024